| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Serina Therapeutics, Inc. (SER) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. SER is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.33M | $6.03M | - | |
| CEO | 230.1K | $416.5K | - | |
| Dir | 92.0K | $166.5K | - | |
| VP | 85.6K | $154.9K | - | |
| Dir | 10.1K | $18.3K | +10.1K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Mintz Steven | Director | Buy | 12,380 | $9.76 | $120,827.18 | +142.2% | -18.1% | -45.2% | |
| May 20, 2024 | Bailey Gregory | Director | Buy | 100 | $9.00 | $900.00 | New | -19.1% | -42.9% | |
| Aug 13, 2019 | Juvenescence Ltd | 10% Owner | Buy | 19,000 | $0.00 | - | +0.1% | - | - | |
| Dec 10, 2018 | West Michael D | Chief Executive Officer | Buy | 4,000 | $3.86 | $15,442.80 | +34.9% | - | - |